Boonen to return to racing next week

Tom Boonen Kuurne

Tom Boonen is to return to competitive cycling next week, after being suspended by his Quick Step team as a result of failing an out-of-competition test for cocaine.

Boonen was suspended by the team after he was found to have taken cocaine recreationally - the second time the rider has tested positive for the drug in out-of-competition tests in less than a year.

Quick Step hope that Boonen will be allowed to ride in this year's Tour de France, and are prepared to fight for his place at the event. According to a report from the Associated Press, Quick Step team manager Patrick Lefevere will take the case to an arbitration court in Paris to obtain a ruling allowing Boonen to ride.

Last year, Tour de France organiser ASO refused Boonen a place at its race as a result of his cocaine positive. Although an out-of-competition failure for cocaine does not draw a sanctions or a suspension from the Union Cycliste Internationale (UCI), ASO felt that Boonen had brought the sport into disrepute. ASO has already stated that Boonen is not welcome at this year's Tour, particularly as it's a repeat offence.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Nigel Wynn
Former Associate Editor

Nigel Wynn worked as associate editor on CyclingWeekly.com, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, CyclingWeekly.com would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, an exceptional person to work with - his presence is sorely missed.